Drugmaker will donate meds for US push to end HIV epidemic

WASHINGTON — The Health and Human Services Department announced Thursday that California-Based Gilead Sciences Inc. has agreed to donate medications that reduce the risk of HIV transmission for up to 200,000 people a year.

"Will help us achieve our goal of ending the HIV epidemic in America!" President Donald Trump said in a celebratory tweet.

The pledge may last up to 11 years, said HHS Secretary Alex Azar. Gilead will donate its Truvada prevention pill until a second-generation version becomes available.

The Trump administration has set a goal of ending the HIV epidemic in the U.S. within 10 years.

Carl Schmid of the AIDS Institute called the donation "a really significant step," saying it will make the drug available to uninsured people. It lists for more than $20,000 per patient, per year.

Gilead Sciences said in a news release that the medication donation is one of the largest ever made in the United States and is part of the company's ongoing initiatives to help ensure that everyone who can benefit from the medicine is able to access it.

HIV is the virus that causes AIDS.

Must Read

Turkish leader wades into Qatar dispute with Gulf...

Jul 24, 2017

Turkey's president has waded into the diplomatic crisis gripping Qatar and four other Arab nations...

The Latest: Kuwait's emir quickly ends troubled...

Dec 5, 2017

Kuwait's emir has quickly ended a troubled summit of the Gulf Cooperation Council amid the ongoing...

Irish border dispute looms large over the UK-EU...

Oct 15, 2018

Britain and the European Union are stuck on the tricky question of how the Irish border fits into...

Lawyer: Timbuktu residents felt shame after sites...

Aug 24, 2016

By reducing historic mausoleums in Timbuktu to dusty piles of rubble, Islamic extremists desecrated...

East Timor, Australia open talks on maritime...

Aug 29, 2016

East Timor and Australia have begun conciliation talks in their bitter legal battle to set a...